Lupin inaugurates R&D centre for inhalation products in Florida

08 Aug 2015 Evaluate

Drug major Lupin has opened a research and development (R&D) centre for inhalation products at Coral Springs in Florida, the US.  The facility will focus on the R&D of inhalation products for the treatment of asthma, allergic rhinitis, chronic obstructive pulmonary diseases and other lung diseases.

With the talent and resources Florida provides, the company’s Coral Springs expansion will further strengthen its ability to bring quality, affordable pharmaceuticals to patients in the United States and other key markets globally.

Lupin is an innovation led transnational pharmaceutical company producing and developing a wide range of branded & generic formulations, APIs and biotechnology products.

 

Lupin Share Price

2137.15 -27.90 (-1.29%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×